Home » TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage
TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage
TriNetX is partnering with the FDA’s Sentinel Operations Center at the Harvard Pilgrim Health Care Institute (HPHCI) to monitor priority drugs used for treating hospitalized COVID-19 patients.
The institute is using TriNetX's de-identified COVID-19 clinical data set to support studies for monitoring sedatives and other drugs used to assist with respiratory disease and other coronavirus-related conditions.
The projects will look at inpatient and outpatient drug use to identify usage patterns that could signal possible drug shortages.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May